Procurement in non-Food FMCG Industry

  • Macro-economics/ regulation

  • Sourcing dynamics/ challenges

  • Coping mechanisms

  • Sourcing cost reductions by 10-15%

  • Client was looking to launch select products in skincare and OTC segments in Nigeria
  • The objective was to understand:
    • Macro, political/regulatory, and other domestic factors impacting sourcing decisions in the country
    • Manufacturing footprint and capabilities of FMCG MNCs and major local players operating in Nigeria
    • Sourcing dynamics of finished goods and raw materials in the non-food FMCG domain
  • In-depth secondary and primary research was conducted to understand:
    • Macroeconomic, infrastructure, and other domestic factors impacting the business environment in Nigeria
    • Manufacturing footprints of players, and the extent of finished goods imports across categories
    • Sourcing patterns of finished goods and raw materials, as well as the macroeconomic/ regulatory/political factors shaping the sourcing decisions
    • Potential bottlenecks in sourcing
  • Helped the client to identify/ ascertain:
    • Manufacturing facilities of key players, degree of imports (finished goods and raw materials – across categories)
    • Impact of import restrictions (due to currency devaluation) and other domestic factors on from sourcing
    • Coping mechanisms of companies in dealing with sourcing challenges
    • Key distributors for raw materials
    • Critical success factors for procurement of FMCG players operating in Nigeria
    • The approach to reduce costs by up to 15% for sourcing raw materials, compared to the existing scenario
Thank you for sharing your details

Your file will start downloading automatically

If it does not download within 1 minute,

Share this on

What we have done

Opportunity assessment and market attractiveness for one of the top 10 pharmaceutical major
What we are proud of

Benchmarked therapeutic areas with high clinical and market potential

Developed potential market scenarios based on client needs

Assessing viability of entering the NSCLC market
What we are proud of

Evaluated unmet needs to identify potential entry points

Conducted a deep-dive study of key assets and key players

Supplier assessment and industry benchmarking for a global top 10 pharmaceutical company
What we are proud of

Optimised vendor-associated costs across geographies

Identified billing arrangements across law firms

Assessment of GCC pharmaceutical market for a global European pharma major
What we are proud of

Analysed potential for entry into the GCC pharmaceutical market

Assessed possible market drivers and barriers to entry

Product launch strategy for European biopharmaceutical company
What we are proud of

Identified geographical concentration of demand

Designed optimal distribution channel configuration

Research on a multiple sclerosis drug with help from global neurologists
What we are proud of

Assessed the target market size, key competitors and current pricing range

Enabled the client to take informed decisions thereby increasing market penetration

Patient treatment pathway analysis for venom allergies
What we are proud of

Increased customer/patient satisfaction and conversion rate

Gained a better understanding of stakeholders’ and patients’ behaviour along the pathway